Published in Atherosclerosis on March 19, 2009
Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res (2010) 1.10
Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients (2012) 1.07
Effect of HDL composition and particle size on the resistance of HDL to the oxidation. Lipids Health Dis (2010) 0.95
High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study. Arthritis Res Ther (2012) 0.88
Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity. J Res Med Sci (2012) 0.87
A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. FASEB J (2012) 0.86
Childhood adversity, adult neighborhood context, and cumulative biological risk for chronic diseases in adulthood. Psychosom Med (2014) 0.85
Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression. PLoS One (2014) 0.83
Serum lipids, apolipoproteins, and mortality among coronary artery disease patients. Biomed Res Int (2014) 0.83
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association. Circulation (2016) 0.83
Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors. J Neural Transm (Vienna) (2011) 0.80
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study. Eur Heart J (2015) 0.79
Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease. Bosn J Basic Med Sci (2011) 0.77
Endurance training enhances LXRα gene expression in Wistar male rats. Eur J Appl Physiol (2013) 0.77
Low high-density lipoprotein cholesterol level is a significant risk factor for development of type 2 diabetes: Data from the Hawaii-Los Angeles-Hiroshima study. J Diabetes Investig (2013) 0.77
Age- and Gender-Normalized Coronary Incidence and Mortality Risks in Primary and Secondary Prevention. Cardiol Res (2012) 0.76
Atherogenic dyslipidemia. Indian J Endocrinol Metab (2013) 0.76
Markers of cardiovascular risk in postmenopausal women with type 2 diabetes are improved by the daily consumption of almonds or sunflower kernels: a feeding study. ISRN Nutr (2012) 0.75
Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators. Prev Med Rep (2017) 0.75
Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men. J Clin Biochem Nutr (2014) 0.75
Low HDL levels in sepsis versus trauma patients in intensive care unit. Ann Intensive Care (2017) 0.75
Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians. Diabetologia (2015) 0.75
State of the Art on Functional Virgin Olive Oils Enriched with Bioactive Compounds and Their Properties. Int J Mol Sci (2017) 0.75
Emotional and instrumental support during childhood and biological dysregulation in midlife. Prev Med (2015) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ (2000) 6.10
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet (2001) 4.60
Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet (2000) 4.55
Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51
Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet (1974) 4.40
Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet (2001) 4.39
The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med (2000) 4.29
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J (1994) 4.02
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92
Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med (1995) 3.90
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet (1998) 3.85
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol (2000) 3.78
The diet and 15-year death rate in the seven countries study. Am J Epidemiol (1986) 3.69
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
Smoking and myocardial infarction. Lancet (1975) 3.42
Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15
Job strain in relation to body mass index: pooled analysis of 160 000 adults from 13 cohort studies. J Intern Med (2011) 3.14
Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med (1994) 3.11
Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J (2002) 3.09
Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08
Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04
Early life experience and adult cardiovascular disease: longitudinal and case-control studies. Int J Epidemiol (1991) 3.02
Increasing prevalence of diabetes mellitus in Oman. Diabet Med (2002) 2.98
Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89
Probability of middle-aged men developing coronary heart disease in five years. Circulation (1972) 2.88
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA (1995) 2.87
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology (2006) 2.70
Bias due to non-participation and heterogenous sub-groups in population surveys. J Chronic Dis (1983) 2.62
Rotating shift work and the metabolic syndrome: a prospective study. Int J Epidemiol (2009) 2.60
Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ (2000) 2.56
Standards for the hospital management of stroke patients. J R Coll Physicians Lond (1994) 2.54
Self-reported wheezing and allergic rhinitis in children and traffic density on street of residence. Ann Epidemiol (1994) 2.53
Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir (1986) 2.52
The association between self-reported symptoms of asthma and allergic rhinitis and self-reported traffic density on street of residence in adolescents. Epidemiology (1996) 2.44
Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Münster, Germany. Allergy (2003) 2.44
Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation (2001) 2.43
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur Respir J (1999) 2.35
Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology (2000) 2.34
Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing (1999) 2.34
Body mass index and the risk of Parkinson disease. Neurology (2006) 2.28
Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Belgian heart disease prevention project: incidence and mortality results. Lancet (1983) 2.23
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation (1997) 2.12
Factors affecting the 5 year survival rate of men following acute coronary heart disease. Am Heart J (1977) 2.10
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) Am J Epidemiol (1995) 2.09
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J (1993) 2.07
Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord (2004) 2.07
Total cholesterol and the risk of Parkinson disease. Neurology (2008) 2.06
Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J (Clin Res Ed) (1983) 2.05
The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes (Lond) (2005) 2.05
Weekly variation of acute myocardial infarction. Increased Monday risk in the working population. Circulation (1994) 2.02
The seven countries study: 2,289 deaths in 15 years. Prev Med (1984) 1.95
Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol (1975) 1.94
A primary preventive study of Gothenburg, Sweden. Prev Med (1972) 1.92
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J (2000) 1.90
Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health (1997) 1.82
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80
A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis (1976) 1.80
Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women. Diabetologia (2003) 1.79
Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey. Eur Heart J (2003) 1.77